Is Europe’s medicine problem the price of not being a federal union?

Europe’s pharmaceutical sector is under pressure — from rising costs and medicine shortages to geopolitical tensions and differing access to medicines across EU member states.In this episode of the EU Perspectives podcast, host Jennifer Baker speaks with:Alessandra Moretti, Member of the European Parliament (S&D)Ines Windisch, Head of Corporate Affairs & Sustainability at Zentiva GroupAndrew Bounds, EU correspondent at the Financial TimesWhat’s driving these challenges and what does it mean for the future of healthcare in Europe?Listen now and join the conversation.